Comparative effectiveness of nucleos(t)ide analogues in chronic hepatitis B patients undergoing cytotoxic chemotherapy.

about

Comparative effectiveness of nucleos(t)ide analogues in chronic hepatitis B patients undergoing cytotoxic chemotherapy.

Item

http://www.wikidata.org/entity/Q40642803

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

2016年论文

@zh

2016年论文

@zh-cn

name

Comparative effectiveness of n ...... rgoing cytotoxic chemotherapy.

@en

type

Item

label

Comparative effectiveness of n ...... rgoing cytotoxic chemotherapy.

@en

prefLabel

Comparative effectiveness of n ...... rgoing cytotoxic chemotherapy.

@en

P1476

Comparative effectiveness of n ...... rgoing cytotoxic chemotherapy.

@en

P2093

Chao-Ming Tseng

http://www.w3.org/2001/XMLSchema#string

Chi-Yang Chang

http://www.w3.org/2001/XMLSchema#string

Jaw-Town Lin

http://www.w3.org/2001/XMLSchema#string

Lein-Ray Mo

http://www.w3.org/2001/XMLSchema#string

Tai-Been Chen

http://www.w3.org/2001/XMLSchema#string

Yao-Chun Hsu

http://www.w3.org/2001/XMLSchema#string

P2860

Chronic hepatitis B: update 2009

Hepatitis B virus epidemiology, disease burden, treatment, and current and emerging prevention and control measures.

Hepatitis B reactivation in patients with hepatocellular carcinoma undergoing systemic chemotherapy.

2-Year GLOBE trial results: telbivudine Is superior to lamivudine in patients with chronic hepatitis B.

Asian-Pacific consensus statement on the management of chronic hepatitis B: a 2012 update.

Management of hepatitis B reactivation in patients receiving cancer chemotherapy.

Systematic review: lamivudine prophylaxis for chemotherapy-induced reactivation of chronic hepatitis B virus infection.

Prevalence of hepatitis B virus marker positivity and evolution of hepatitis B virus profile, during chemotherapy, in patients with solid tumours.

Comprehensive analysis of risk factors associating with Hepatitis B virus (HBV) reactivation in cancer patients undergoing cytotoxic chemotherapy

Lamivudine prophylaxis is effective in reducing hepatitis B reactivation and reactivation-related mortality in chemotherapy patients: a meta-analysis.

P304

421-429

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/AJCO.12520

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2016-07-20T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27435683

http://www.w3.org/2001/XMLSchema#string